Skip to main content
Clinical Trials/EUCTR2008-003676-22-DE
EUCTR2008-003676-22-DEActive, not recruitingNot Applicable

A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure – A Pilot Study (PRONTO) - PRONTO

The Medicines Company0 sites140 target enrollmentStarted: January 9, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
140

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age 18 years or older
  • 2. Presentation consistent with AHF and pulmonary congestion on physical examination as evidenced by rales.
  • 3. Baseline SBP (immediately prior to initiation of study drug) of =160 mm Hg
  • 4. Dyspnea score (sitting) of at least 5 on a 10 cm visual analog scale (VAS)
  • 5. Requires IV antihypertensive therapy to lower BP
  • 6. Written informed consent before initiation of any study related procedures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1. Administration of an agent (IV or oral) for the treatment of elevated BP within the previous 2 hours of randomization. (Previous short acting non- IV nitrates, CPAP and BiPAP are permitted)
  • 2. Chest pain and/or electrocardiogram (ECG) with ST segment changes consistent with acute coronary syndrom.
  • 3. Known or suspected aortic dissection
  • 4. Acute Myocardial Infarction (AMI) within the prior 14 days
  • 5. Dialysis dependant renal failure
  • 6. Requirement for immediate endotracheal intubation
  • 7. Positive pregnancy test, known pregnancy or breast feeding female
  • 8. Intolerance or allergy to calcium channel blockers
  • 9. Allergy to soybean oil or egg lecithin
  • 10. Known liver failure, cirrhosis or pancreatitis
  • 11. Prior directives against advanced life support (no code status)
  • 12. Participation in other clinical research studies involving the evaluation of other investigational drugs or devices within 30 days of enrollment

Investigators

Similar Trials

A Safety and Efficacy Study of Blood... | Clinical Trial